Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sarepta Therapeutics Inc (NASDAQ:SRPT)

16.95
Delayed Data
As of Jun 27
 -1.57 / -8.48%
Today’s Change
8.00
Today|||52-Week Range
41.97
-56.07%
Year-to-Date
3 Tempting Stocks to Avoid
Jun 26 / MotleyFool.com - Paid Partner Content
Fake Tweets Sink Stocks: What Happens When Scammers Impersonate Research Firms
Jun 21 / MotleyFool.com - Paid Partner Content
Sarepta Push for Duchenne Drug Approval Helped by Clinical Trial Changes
Jun 23 / TheStreet.com - Paid Partner Content
Stocks: 4 things to know before the open
Jun 07 / CNNMoney.com

Today’s Trading

Previous close18.52
Today’s open18.22
Day’s range16.65 - 18.75
Volume3,039,084
Average volume (3 months)6,048,274
Market cap$887.6M
Dividend yield--
Data as of 06/27/2016

Growth & Valuation

Earnings growth (last year)-53.39%
Earnings growth (this year)+9.94%
Earnings growth (next 5 years)+0.37%
Revenue growth (last year)-87.16%
P/E ratioNM
Price/Sales1,302.11
Price/Book4.44

Competitors

 Today’s
change
Today’s
% change
LCILannett Company Inc-1.41-5.82%
INSYINSYS Therapeutics I...-1.16-9.19%
SUPNSupernus Pharmaceuti...-0.39-2.11%
SAGESAGE Therapeutics In...-1.58-5.54%
Data as of 06/27/2016

Financials

Next reporting dateAugust 4, 2016
EPS forecast (this quarter)-$1.23
Annual revenue (last year)$1.3M
Annual profit (last year)-$220.0M
Net profit margin-17,560.26%

Profile

Sector
Health Technology
Industry
Biotechnology
Senior VP, Chief Executive &
Medical Officer
Edward M. Kaye
Head-Operations &
Vice President
Gavin T. Malenfant
Corporate headquarters
Cambridge, Massachusetts

Forecasts

Partner Offers

Search for Jobs